
1. j korean med sci. 2015 nov;30(11):1618-24. doi: 10.3346/jkms.2015.30.11.1618.
epub 2015 oct 16.

hepatocellular carcinoma risk compensated cirrhosis patients elevated hbv
dna levels according serum aminotransferase levels.

lee j(1), sinn dh(1), kim jh(1), gwak gy(1), kim hs(2), jung sh(2), paik yh(1),
choi ms(1), lee jh(1), koh kc(1), yoo bc(1), paik sw(1).

author information: 
(1)department medicine, samsung medical center, sungkyunkwan university school
of medicine, seoul, korea.
(2)biostatistics clinical epidemiology center, samsung medical center, seoul,
korea.

comment in
    j korean med sci. 2016 may;31(5):824.
    j korean med sci. 2016 may;31(5):825-6.

sometimes, hepatitis b virus (hbv)-related cirrhotic patients normal
aminotransferase levels closely followed-up elevation of
aminotransferase levels instead prompt antiviral therapy (avt). analyzed
the long-term hepatocellular carcinoma (hcc) risk according the
aminotransferase levels retrospective cohort 1,468 treatment-naïve,
hbv-related, compensated cirrhosis patients elevated hbv dna levels (≥ 2,000
iu/ml). based aminotransferase levels, patients categorized normal
(< 40 u/l, n = 364) elevated group (≥ 40 u/l, n = 1,104). median 
5.3 yr follow-up (range: 1.0-8.2 yr), hcc developed 296 (20%) patients. the
5-yr cumulative hcc incidence rate higher patients elevated
aminotransferase level, low normal aminotransferase level (17% vs.
14%, p = 0.004). follow-up, 270/364 (74%) patients normal
aminotransferase levels experienced elevation aminotransferase levels, avt
was initiated 1,258 (86%) patients. less patients normal aminotransferase
levels received avt (70% vs. 91%, p < 0.001) median time start avt was
longer (17.9 vs. 2.4 months, p < 0.001). avt duration independent factor
associated hcc, median duration avt shorter (4.0 vs. 2.6 yr, p < 
0.001) patients normal aminotransferase levels. hcc risk of
compensated cirrhosis patients normal aminotransferase level low, and
avt duration associated lowered hcc risk, indicating prompt avt
should strongly considered even normal aminotransferase levels.

doi: 10.3346/jkms.2015.30.11.1618 
pmcid: pmc4630478
pmid: 26539006  [indexed medline]

